SAFC Biosciences provides an integrated services package in mammalian cell culture media development to support customer programs from pre-clinical and clinical development through to commercialization. Analytical and regulatory support is also part of the package to directly benefit speed-to-market times.
Headquartered in Lenexa, Kansas, SAFC Biosciences has six production facilities in the US, Europe and Australia and employs 600 people. Main product lines are EX-CELL™ serum-free media; serum-based products; LONG™ growth factors and BIOEAZE™ disposable bioprocessing systems.
As the basis for its biopharmaceutical expansion program, Sigma-Aldrich acquired JRH Biosciences from Australia's CSL Limited in February 2005 creating SAFC Biosciences.